Health care professionals, patients and even the governor are calling on North Carolina's congressional delegation to protect Medicaid.

Cardinal Health Inc. closed 5.54% short of its 52-week high of $139.50, which the company achieved on April 3rd.

This was the stock's third consecutive day of losses.

BofA raised the firm’s price target on Cardinal Health (CAH) to $155 from $150 and keeps a Buy rating on the shares. The recent introduction of ...

Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Buy rating on Cardinal Health (CAH – Research Report). The ...

The stock's rise snapped a four-day losing streak.

The Trump administration and lawmakers at the state and federal level have proposed deep and dangerous cuts to Medicaid and other programs that would take essential health care away from Florida ...

CAH stock has surged 12.5% over the past three months, outpacing the Health Care Select Sector SPDR Fund’s (XLV) 6.5% gain over the same time frame. Over the longer term, Cardinal’s ...

Cardinal Health (CAH) closed the latest trading day at $128.88, indicating a -1.2% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 3.46%.

Public health plays a critical role in shaping a nation’s well-being and health-care delivery ... such a workforce is essential for civil society organisations, academic institutions, and ...